Buy Skyrizi (Risankizumab) Online

Skyrizi (risankizumab) is a prescription medication used to treat plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is a monoclonal antibody that works by blocking the interleukin-23 (IL-23) pathway, which is involved in the development and progression of psoriasis.

Uses

Skyrizi is used to treat plaque psoriasis in adults. Plaque psoriasis is a chronic autoimmune disease that causes red, scaly patches of skin to form. Skyrizi can help to clear these patches and improve the appearance and comfort of the skin.

Storage Conditions

Skyrizi should be stored in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze. Skyrizi can be kept at room temperature for up to 24 hours.

Mechanism of Action

Skyrizi is a monoclonal antibody that binds to the p19 subunit of IL-23 and blocks its interaction with the IL-23 receptor. IL-23 is a cytokine that plays a key role in the development and progression of psoriasis. By blocking IL-23, Skyrizi can help to reduce inflammation and improve the symptoms of psoriasis.

How to Use

Skyrizi is administered by subcutaneous injection every 12 weeks. The recommended dose is 150 mg. Skyrizi should be injected by a healthcare professional.

Important Safety Information

Skyrizi can increase the risk of serious infections, including tuberculosis. Before starting Skyrizi, your doctor will test you for tuberculosis. Skyrizi can also reactivate latent tuberculosis infection.

Skyrizi can also increase the risk of other side effects, such as:

• Allergic reactions
• Inflammatory bowel disease (IBD)
• Psoriasis worsening
• Injection site reactions
• Upper respiratory tract infections
• Headache
• Diarrhea
• Nausea
• Fatigue

Indications

Skyrizi is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Precautions

Skyrizi should be used with caution in patients with a history of serious infections, tuberculosis, IBD, or other autoimmune diseases.

Skyrizi should not be used in patients who have a history of severe allergic reactions to Skyrizi or other biologic medications.

Interactions

Skyrizi may interact with other medications, including live vaccines and biologic medications. Be sure to tell your doctor about all of the medications you are taking before starting Skyrizi.

Contraindications

Skyrizi is contraindicated in patients with a history of severe allergic reactions to Skyrizi or other biologic medications.

Overdose

There is no known overdose of Skyrizi.

Side Effects

The most common side effects of Skyrizi are upper respiratory tract infections, headache, diarrhea, nausea, fatigue, and injection site reactions.

More serious side effects of Skyrizi include serious infections, IBD, psoriasis worsening, and allergic reactions.

If you experience any side effects while taking Skyrizi, be sure to tell your doctor.

Additional Information

Skyrizi was approved by the U.S. Food and Drug Administration (FDA) in 2019.